Accrual
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review
Background: Racial and ethnic minorities (REMs) continue to be underrepresented in clinical trials despite the 1993 National Institu...
Accrual and retention of diverse patients in psychosocial cancer clinical trials
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to ...

Trending Topics

Features

Download and distribute powerful vaccination QI resources for your community.

Sign up now to support health equity and sustainable health outcomes in your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.

The single most important purpose of our healthcare system is to reduce patient risk for an acute event.